IL27 and neoplasm: At lower doses, AAV-IL-27 did not inhibit B16 tumor growth significantly (Figures 2A,B), while at a higher doses (Figure 2C), intra-tumoral injection of AAV-IL-27 significantly inhibited the growth of B16 tumors.